Laspas P, Hartmann A, Scholz I, Hoffmann E, Khawaja A, Lackner K
Invest Ophthalmol Vis Sci. 2024; 65(14):4.
PMID: 39625443
PMC: 11620004.
DOI: 10.1167/iovs.65.14.4.
Ruan Y, Buonfiglio F, Gericke A
Handb Exp Pharmacol. 2023; 285:453-505.
PMID: 38082203
DOI: 10.1007/164_2023_702.
Kawae T, Nomura T, Iwaki D, Nakashima Y, Fudeyasu K, Kataoka H
Healthcare (Basel). 2022; 10(7).
PMID: 35885722
PMC: 9315960.
DOI: 10.3390/healthcare10071196.
Madjedi K, Stuart K, Chua S, Luben R, Warwick A, Pasquale L
Ophthalmology. 2022; 129(9):986-996.
PMID: 35500606
PMC: 10444694.
DOI: 10.1016/j.ophtha.2022.04.023.
Wu A, Khawaja A, Pasquale L, Stein J
Eye (Lond). 2019; 34(1):12-28.
PMID: 31595027
PMC: 7002596.
DOI: 10.1038/s41433-019-0603-z.
Topical treatment of glaucoma: established and emerging pharmacology.
Dikopf M, Vajaranant T, Edward D
Expert Opin Pharmacother. 2017; 18(9):885-898.
PMID: 28480761
PMC: 7794042.
DOI: 10.1080/14656566.2017.1328498.
Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.
Donegan R, Lieberman R
J Med Chem. 2015; 59(3):788-809.
PMID: 26356532
PMC: 5547565.
DOI: 10.1021/acs.jmedchem.5b00828.
Bradyarrhythmias secondary to topical levobunolol hydrochloride solution.
Lin L, Wang Y, Chen Y, Liu M
Clin Interv Aging. 2014; 9:1741-5.
PMID: 25342892
PMC: 4206249.
DOI: 10.2147/CIA.S69420.
Systemic medication and intraocular pressure in a British population: the EPIC-Norfolk Eye Study.
Khawaja A, Chan M, Broadway D, Garway-Heath D, Luben R, Yip J
Ophthalmology. 2014; 121(8):1501-7.
PMID: 24702754
PMC: 4109027.
DOI: 10.1016/j.ophtha.2014.02.009.
Current concepts of pharmacotherapy in hypertension--ophthalmically administered beta blockers and their cardiopulmonary effects.
Sica D
J Clin Hypertens (Greenwich). 2001; 3(3):175-8.
PMID: 11416704
PMC: 8099244.
DOI: 10.1111/j.1524-6175.2001.00466.x.
Pharmacological therapy for glaucoma: a review.
Hoyng P, van Beek L
Drugs. 2000; 59(3):411-34.
PMID: 10776828
DOI: 10.2165/00003495-200059030-00003.
Acute effect of metipranolol on the retinal circulation.
Wolf S, Werner E, Schulte K, Reim M
Br J Ophthalmol. 1998; 82(8):892-6.
PMID: 9828772
PMC: 1722719.
DOI: 10.1136/bjo.82.8.892.
Sublingual timolol--an alternative to topical medication in glaucoma?.
Sadiq S, Vernon S
Br J Ophthalmol. 1996; 80(6):532-5.
PMID: 8759264
PMC: 505526.
DOI: 10.1136/bjo.80.6.532.
A radioautographic study on the incorporation of 14C-bupranolol (beta-blocking agent) into the rabbit eye.
Tsukahara S, Yoshida K, Nagata T
Histochemistry. 1980; 68(3):237-44.
PMID: 7462003
DOI: 10.1007/BF00493253.
Atenolol 4% eyedrops in glaucoma simplex.
Sterk C
Doc Ophthalmol. 1980; 48(2):309-14.
PMID: 7398531
DOI: 10.1007/BF00141458.
Timolol in operated closed-angle glaucoma.
Phillips C
Br J Ophthalmol. 1980; 64(4):240-6.
PMID: 7387959
PMC: 1043664.
DOI: 10.1136/bjo.64.4.240.
Absorption of ocular timolol.
Alvan G, Calissendorff B, Seideman P, Widmark K, Widmark G
Clin Pharmacokinet. 1980; 5(1):95-100.
PMID: 7363532
DOI: 10.2165/00003088-198005010-00004.
A dose-response study of oral atenolol administered once daily in patients with raised intra-ocular pressure.
Stenkula E, Wettrell K
Graefes Arch Clin Exp Ophthalmol. 1982; 218(2):96-8.
PMID: 7042481
DOI: 10.1007/BF02153719.
A major pathway for the regulation of intraocular pressure.
Sears M, Mead A
Int Ophthalmol. 1983; 6(3):201-12.
PMID: 6309689
DOI: 10.1007/BF00141129.
Beta adrenergic receptors in pigmented ciliary processes.
Trope G, Clark B
Br J Ophthalmol. 1982; 66(12):788-92.
PMID: 6293532
PMC: 1039930.
DOI: 10.1136/bjo.66.12.788.